Medifast, Inc. (MED)
| Market Cap | 112.76M -21.5% |
| Revenue (ttm) | 385.79M -36.0% |
| Net Income | -18.67M |
| EPS | -1.70 |
| Shares Out | 10.35M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 44,271 |
| Open | 10.77 |
| Previous Close | 10.76 |
| Day's Range | 10.62 - 10.94 |
| 52-Week Range | 9.22 - 15.46 |
| Beta | 0.56 |
| Analysts | Hold |
| Price Target | 12.00 (+10.19%) |
| Earnings Date | May 4, 2026 |
About MED
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND,... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to one analyst, the rating for MED stock is "Hold" and the 12-month stock price target is $12.0.
News
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter...
Medifast Announces Cooperation Agreement with Steamboat Capital
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Di...
Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
BALTIMORE--(BUSINESS WIRE)--As part of its continued focus on improving metabolic health, Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is available for re...
Medifast Earnings Call Transcript: Q4 2025
Q4 2025 saw revenue drop 36.9% year-over-year due to a smaller coach base, but coach productivity rose 6%, marking the first positive trend since 2022. The company is transitioning to a metabolic health focus, expects new product launches in late 2026, and targets profitability improvements starting Q4 2026.
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full ye...
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full ...
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation o...
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, premiered its newest docuseries episode, “Health...
Medifast Announces Planned Leadership Transition
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabo...
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
BALTIMORE--(BUSINESS WIRE)--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report “Metabolic Health in America: Awareness, Attitudes and Action.” The report includes findi...
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis ...
Medifast Earnings Call Transcript: Q3 2025
Q3 revenue and EPS were at the high end of guidance, but revenue fell 36% year-over-year due to a sharp decline in active coaches. The company is shifting focus to metabolic health, launching new products in 2026, and expects stabilization in coach productivity and revenue per coach in the coming quarters.
Medifast Announces Third Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended Septem...
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a n...
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quar...
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
BALTIMORE--(BUSINESS WIRE)--With more than 90% of U.S. adults classified as metabolically unhealthy1, the silent crisis of metabolic dysfunction continues to escalate. This condition can be linked to ...
Medifast Earnings Call Transcript: Q2 2025
Q2 2025 revenue and EPS exceeded guidance despite a 37% revenue drop and a 33% decline in active coaches. New pricing and incentive programs were launched, and the company remains debt-free with strong cash reserves. GLP-1 trends and metabolic health remain central to strategy.
Medifast Announces Second Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter...
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quart...
Medifast Earnings Call Transcript: Q1 2025
Q1 2025 revenue and EPS were within guidance, but revenue fell 33.8% year-over-year due to fewer active coaches. New coach cohorts and product lines like Ascend are showing promise, with improved productivity and customer acquisition. Cash position remains strong with no debt.
Medifast Announces First Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ...
Medifast Earnings Call Transcript: Q4 2024
Revenue and net income declined sharply year-over-year, but cost savings and new product launches like OPTAVIA ASCEND helped stabilize key metrics. Coach productivity is showing signs of improvement, and the company maintains a strong cash position with no debt.
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter...
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourt...
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product l...